China National Accord Medicines Corporation Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
4.78 | 69.4 | -93.11% | 7.8 | -38.75% |
| P/S |
|
0.1 | 6.51 | -98.46% |
|
|
| P/BV |
|
0.46 | 3.96 | -88.37% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
8.28 | 11.85 | -30.12% |
|
|
| Ev/S |
|
0.3049 | 5.98 | -94.9% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.0691 | 0.0396 | 74.52% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
1/10
|
3.48 | 20.39 | -82.93% | 5.02 | -30.7% |
| ROE |
|
10.15 | 11.95 | -15.03% |
|
|
| ROA |
|
3.23 | 5.4 | -40.2% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
2.13 | 16.23 | -86.88% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
6/10
|
2.18 | 14.63 | -85.1% | 1.59 | +37.06% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
3.56 | 3.6 | -1.21% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
6.04 | 1.83 | 229.52% | 3.07 | +96.73% |
| Number of years of dividend growth |
|
1 | 1.44 | -30.43% | ||
| DSI |
|
0.8571 | 0.9113 | -5.94% |
|
|
| Average dividend growth |
|
18.98 | 10.4 | 82.61% |
|
|
| Average percentage for 5 years |
|
3.07 | 1.14 | 168.83% |
|
|
| Average percentage for payments |
|
31.98 | 44.8 | -28.61% |
|
|
| Difference from average difference in sector |
|
4.21 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
6/10
|
45.02 | 61.43 | -26.71% | ||
| Growth impulse Ebitda in 5 years |
|
94.95 | 158.62 | -40.14% | ||
| Growth impulse Net Income in 5 years |
|
25.8 | 66.93 | -61.45% | ||
| Growth impulse FCF in 5 years |
|
48.98 | 248.41 | -80.28% | ||
| Growth impulse EPS in 5 years |
|
22.01 | 73.29 | -69.97% |
IP Score
6.41/10
